Skip to main content

Pharmacological Calcium Sensitivity Modulation of Cardiac Myofilaments

  • Conference paper
Molecular and Cellular Aspects of Muscle Contraction

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 538))

  • 493 Accesses

Abstract

As is well known, force generation and contractility of the heart may be controlled by calcium by way of regulating crossbridge attachment and the transition of attaching crossbridges into a force-generating state. These calcium activation processes do not occur in an all-or-none manner, but may be graded e.g. by altering the degree of calcium occupancy of troponin C (e.g. Pan and Solaro, 1987). Calcium occupancy depends on the free calcium concentration in the myoplasm in the range of 0.1 to 10 μM, but also, of course, on the calcium affinity of troponin C. Thus, at an intermediate cytosolic Ca2+ concentration allowing force to reach half maximum activation, any increase in calcium affinity would increase calcium occupancy and hence force and contractility. Thus, a lower Ca2+ concentration (or for that matter a higher pCa50 value) would then be required to reach half maximum activation under these conditions. This we refer to as Ca2+ sensitization of the myofilaments. The term calcium sensitivity modulation then is taken to mean a change in the pCa50 value, i.e. in the level of ionised calcium required for 50% activation of the myofilament activity normalized to the maximum contractile activity at saturating levels of calcium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bowman, P., Haikala, H., and Paul, R. J., 1999, Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitisation, J. Pharmacol. Exp. Ther. 288:316–325.

    PubMed  CAS  Google Scholar 

  • Dohet, C, Al-Hillawi, E., Trayer, I.P., and Rüegg, J. C, 1995, Reconstitution of skinned cardiac fibres with human recombinant cardiac troponin I mutants and troponin C, FEBS Lett. 377:131–134.

    Article  PubMed  CAS  Google Scholar 

  • Edes, I., Kiss, E., Kitada, Y., Powers, F. M., Papp, J. G., Kranias, E.G, and Solaro, R. J., Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac func-tion and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplas-mic reticulum in guinea-pig heart, Circ. Res. 77:107–113.

    Google Scholar 

  • Haikala, H., Nissinen, L., Etemadzadeh, E., Levijoki, J., and Linden, I. B., 1995, Tropo-nin C-mediated calcium sensitisation does not impair relaxation, J. Cardiovasc. Pharmacol. 25:794–801.

    Article  PubMed  CAS  Google Scholar 

  • Haikala, H.,and Pollesello, P., 2000, Calcium sensitivity enhancers, Idrugs 3:1199–1205.

    PubMed  CAS  Google Scholar 

  • Hasenfuss, G., Pieske, B., Castell, M., Kretschmann, B., Maier, L. S., and Just, H., 1998, Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium, Circulation 98:2141–2147.

    Article  PubMed  CAS  Google Scholar 

  • Herzig, J. W., Feile, K., and Rüegg, J. C, 1981a, Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle, Arzneim. Forsch/Drug Res. 31:188–191.

    CAS  Google Scholar 

  • Herzig, J. W., Köhler, H., Pfitzer, G., Rüegg, J. C, and Wölffle, G., 1981b, Cyclic AMP inhibits contractility of detergent treated glycerol extracted cardiac muscle, Pflügers Arch. Europ. J. Physiol. 391:208–212.

    Article  CAS  Google Scholar 

  • Janssen, P. M. L, Datz, N., Zeitz, O., and Hasenfuss, G., 2000, Levosimendan improves diastolic and systolic function in failing human myocardium, Eur. J. Pharmacol. 404:191–199.

    Article  PubMed  CAS  Google Scholar 

  • Kersten, J. R., Montgomery, M. W., Pagel, P. S., and Warltier, D. C, 2000, Levosimen-dan, a new positive inotropic drug, decreases myocardial infarct size via activation of K (ATP) channels, Anaesth. Analog. 90:5–11.

    Article  CAS  Google Scholar 

  • Kögler, H., and Rüegg, J. C, 1997, Cardiac contractility: Modulation of myofibrillar Ca-sensitivity by _-adrenergic stimulation, Isr. J. Med. Sci. 33:1–7.

    PubMed  Google Scholar 

  • Kusuoka, H., Koretsune, Y., Chacko, V. P., Weisfeldt, M. L., Marban, E., 1990, Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? Circ. Res. 66:1268–1276.

    Article  PubMed  CAS  Google Scholar 

  • Lee, J.A., and Allen, D. G., 1991, EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle, Circ. Res. 69:927–936.

    Article  PubMed  CAS  Google Scholar 

  • Lilleberg, J., Nieminen, M. S., Akkila, J., Heikkilär, L., Kuitunen, A., and Lehtonen, L., 1998, Effects of a new calcium sensitizer, levosimendan, on hemodynamics, coronary blood flow and myocardial substrate utilization early after coronary bypass grafting, Eur. Heart J. 19:660–668.

    Article  PubMed  CAS  Google Scholar 

  • Mittmann, K., Jaquet, K., and Heilmeyer,Jr. L. M. G, 1990, A common motif of two adjacent phosphoserines in bovine, rabbit and human cardiac Tnl, FEBS Lett. 273:41–45.

    Article  PubMed  CAS  Google Scholar 

  • Mittmann, K., Jaquet, K., and Heilmeyer,Jr. L. M. G. 1992, Ordered phosphorylation of a duplicated minimal recognition motif for c-AMP-dependent proteinkinase present in cardiac troponin I, FEBS Lett. 302:133–137.

    Article  PubMed  CAS  Google Scholar 

  • Nolan, J., Batin, P. D., Andrews, R., Lindsay, S. J., Brooksby, P., Mullen, M., Baig, W., Flapan, A D., Cowley, A., Prescott, R. J., Neilson, J.M., and Fox, K. A., 1998, Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart), Circulation 98:1510–1516.

    Article  PubMed  CAS  Google Scholar 

  • Paakkonen, K., Sorsa, T., Drakenberg, T., Pollesello, P., Tilgmann, C, Permi, P., Heikkinen, S., Kilpelainen, I., and Annila, A., 2000, Conformations of the regulatory domain of cardiac troponin C examined by residual dipolar couplings, Eur. J. Biochem. 267:6665–72.

    Article  PubMed  CAS  Google Scholar 

  • Packer, M., Bristow, M. A., Cohn, J. D., Colucci, W. S., Fowler, M. B., Gilbert, E.M., and Shusterman, N. H., 1996, The effct of cravedilol on morbidity and mortality in patients with chronic heart failure, N. Engl. J. Med. 334:1349–1355.

    Article  PubMed  CAS  Google Scholar 

  • Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., 1991, Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE study research group, New Engl. Med. J. 325:1468–1475.

    Article  CAS  Google Scholar 

  • Pan, B.S., and Solaro, R. J., 1987, Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers, J. Biol. Chem. 262:7839–7849.

    PubMed  CAS  Google Scholar 

  • Ray, K.P., and England, P. J., 1976, Phosphorylation of the inhibitory subunit of troponin and its effects on the calcium dependence of cardiac myofibril adenosine triphosphatase, FEBS Lett 70:11–16.

    Article  PubMed  CAS  Google Scholar 

  • Rüegg, J. C, 1986, Effects of new inotropic agents on Ca++ sensitivity of contractile proteins, Circulation 73(Suppl III):78–85.

    Google Scholar 

  • Rüegg, J.C, 1998, Cardiac contractility: How calcium activates the myofilaments, Naturwissenschaften 85:575–582.

    Article  PubMed  Google Scholar 

  • Saeki, Y., Kobayashi, T., Minamisawa, S., and Sugi, H., 1997, Proteinkinase A increases the tension cost and unloaded shortening velocity in skinned rat cardiac muscle, J. Mol Cell Cardiol. 29:1655–63.

    Article  PubMed  CAS  Google Scholar 

  • Saeki, Y., Takigiku, K., Iwamoto, H., Yasuda, S., Yamashita, H., Sugiura, S., and Sugi, H., 2001, Protein kinase A increases the rate of relaxation but not the rate of tension development in skinned rat cardiac muscle, Jpn. J. Physiol. 51:427–33.

    Article  PubMed  CAS  Google Scholar 

  • Singh, B. N, Lilleberg, J., Sandell, E. P., Ylönen, V., Lehtonen, L, and Toivonen, L, 1999, Effects of Levosimendan on cardiac arrhythmia: electrophysiological and ambulatory electrocardiographic findings in phase II and phase III clinical studies in cardiac failure, Am. J. Cardiol. 83(12B):16(I)20(I).

    Google Scholar 

  • Slawsky, M. T., Wilson, S. C, Gottlieb, S. S., Greenberg, B. H., Häusslein, E., Hare, J., Hutchins, S., Leier, C. V., LeJemtel, T. H, Loh, E, Nicklas, I, Ogilby, D., Singh, B.M., and Smith, W., 2000, Acute hemodynamics and clinical effect of Levosimendan in patients with severe heart failure, Circulation 102:2222–2227.

    Article  PubMed  CAS  Google Scholar 

  • Solaro, R. J., Gambassi, G, Warshaw, D. M., Keller, M. R., Spurgeon, H. A., Beier, N., and Lakatta, E. G., 1993, Stereoselective actions of thiadiazinones on cardiac myocytes and myofilaments, Circ. Res. 73:981-990. Solaro, R. J., Rüegg, J. C, 1982, Stimulation of Ca2+ binding and ATPase activity of dog cardiac myofibrils by AR-L 115 BS, a novel cardiotonic agent, Circ. Res. 61:290–294.

    Google Scholar 

  • Sorsa, T., Heikkinen, S., Abbott, M. B., Abusamhadneh, E., Laakso, T., Tilgmann, C, Serimaa, R., Annila, A, Rosevear, P. R., Drakenberg, T., Pollesello, P., and Kilpelai-nen, I., 2001, Binding of levosimendan, a calcium sensitizer, to cardiac troponin C, J. Biol. Chem. 276:9337–43.

    Article  PubMed  CAS  Google Scholar 

  • Sys, S.U., and Brutsart, D. L, 1995, Diastolic significance of impaired LV systolic re-laxation in heart failure, Circulation 92:3377–3380.

    Article  PubMed  CAS  Google Scholar 

  • Teramura, S., and Yamakado, T.,1998, Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation, Cardiologia 43:375–383.

    PubMed  CAS  Google Scholar 

  • Wattanapermpool, J., Guo, X., and Solaro, R. J., 1995, The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated, J. Mol. Cell. Cardiol. 27:1383–1391.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, R., Zhao, J.J., and Potter, J. D., 1995, Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C, J. Biol. Chem. 270:30773–30780.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this paper

Cite this paper

Rüegg, J.C. (2003). Pharmacological Calcium Sensitivity Modulation of Cardiac Myofilaments. In: Sugi, H. (eds) Molecular and Cellular Aspects of Muscle Contraction. Advances in Experimental Medicine and Biology, vol 538. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9029-7_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9029-7_37

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4764-4

  • Online ISBN: 978-1-4419-9029-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics